期刊文献+

来氟米特与甲氨蝶呤合用所致的间质性肺炎 被引量:2

Leflunomide combined with methotrexate resulting in interstitial pneumonia
原文传递
导出
摘要 1例77岁女性患者,因类风湿关节炎开始服用来氟米特(LEF)20mg,每天1次,甲氨蝶呤(MTX)12.5mg,每周1次。5个月后出现发热、喘憋、咳嗽、咳痰等症状,发热后第5天停用LEF和MTX。胸部CT:双肺野弥漫性磨玻璃阴影。肺泡灌洗液:细胞总数0.49×106mL-1,巨噬细胞58.50%,淋巴细胞41.50%,中性粒细胞0.00%,嗜酸性粒细胞0.00%,肺孢子菌肺炎阴性。诊断:细菌性肺炎、间质性肺炎(药源性)。治疗:给予吸氧、抗感染、抗炎、利尿、化痰平喘及对症支持治疗,低盐低脂糖尿病饮食。糖皮质激素治疗3d后患者体温恢复正常,10d后复查胸片和胸部CT提示肺间质病变有好转,胸部超声提示胸水较前明显减少。 A 77-year-old female patient with rheumatoid arthritis (RA) was seen because of fever, dyspnea, cough, purulent sputum and interstitial lung changes. LEF (20 mg/day) combined with MTX(12.5mg/week) began before 5 months. The withdrawal of LEF and MTX was on the fifth day after the fever, the chest CT revealed ground glass shadowing and consolidations forming a mosaic pattern in lung fields; bronchi alveolar lavage (BAL) cell: total was 0.49x106/ml, macrophages 58.50%, lymphocytes 41.50%, neutrophils 0.00%, eosinophils 0.00%, PCP negative. Pneumonia, Interstitial Pneumonia (drug- induced ) were diagnosed. The patient underwent oxygen therapy, anti-infection , anti-inflammatory, diuretics, spasmolysis, with low salt and fat diet. The patient's temperature returned to normal after a three days of steroid hormones, the lung lesion was significantly improved on chest X-ray and CT 10 days later, and also pleural effusion was reduced on ultrasonic testing.
出处 《临床药物治疗杂志》 2013年第6期52-55,共4页 Clinical Medication Journal
关键词 间质性肺炎 来氟米特 甲氨蝶呤 不良反应 Interstitial pneumonia Leflunomide Methotrexate Adverse drug reaction
  • 相关文献

参考文献21

  • 1竹内勤,史春虹.抗风湿药的药物性肺损害[J].日本医学介绍,2007,28(3):115-118. 被引量:7
  • 2Schwaiblmair M, Behr W, Haeckel T, et al. Drug Induced Interstitial Lung Disease[J]. Open Respir Med J, 2012, 6: 63-74.
  • 3龙锐,邱峰,朱深银.回顾性分析药源性的间质性肺疾病53例[J].中国临床药理学杂志,2013,29(1):65-67. 被引量:7
  • 4Kunkel G, W Cannon G. Leflunomide in the treatment of rheumatoid arthritis[J]. Expert Rev Clin Immunol, 2006, 2(1): 17-31.
  • 5Donahue KE, Jonas DE, Hansen RA, et al. Drug Therapy for Rheumatoid Arthritis in Adults: An Update[J]. Comparative Effectiveness Reviews, 2012, 55:111-120.
  • 6Carson CW, Cannon GW, Egger MJ, et al. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate[J]. Semin Arthritis Rheum, 1987, 16(3): 186-195.
  • 7Kremer JM, Alarcon GS, Weinblatt ME, et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-assoeiated lung injury in patients with rheumatoid arthritis: a muhicenter study with literature review[J]. Arthritis Rheum, 1997, 40(10): 1829-1837.
  • 8Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature [J]. J Rheumato, 1987, 14(6): 1164-1171.
  • 9Chikura B, Lane S, Dawson JK. Clinical expression of leflunomide-induced pneumonitis[J]. Rheumatology (Oxford), 2009, 48(9): 1065-1068.
  • 10Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study[J]. Arthritis Rheum, 2010, 62(6): 1583-1591.

二级参考文献22

共引文献22

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部